DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
November 21, 2024 09:00 ET
|
DANNCE.AI
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform.
[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 21, 2024 01:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Apheresis Equipment Market Size, Trends and Insights By Product Type...
[Latest] Global Epilepsy Treatment Devices Market Size/Share Worth USD 787.3 Million by 2033 at a 4.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 19, 2024 11:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Epilepsy Treatment Devices Market Size, Trends and Insights By Product Type...
How a 5-Year-Old is Helping Save Lives: New Book by Telestroke CEO & Son Teaches Kids to Spot Stroke Signs
October 29, 2024 08:45 ET
|
Sevaro Health
On World Stroke Day, Sevaro CEO Dr. Raj Narula and son release B.E.F.A.S.T., Be A Superhero, a children’s book teaching kids to recognize stroke symptoms.
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
October 24, 2024 09:00 ET
|
NeuroOne Medical Technologies
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
Trethera Announces Presentation at the Rare Neuroimmune Disorders Symposium Annual Meeting
October 15, 2024 11:48 ET
|
Trethera Corporation
LOS ANGELES, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...
Tevogen Bio Extends Pipeline Prioritizing Oncology and Long COVID
October 11, 2024 12:12 ET
|
Tevogen Bio Inc
Developing therapeutic products that not only treat cancer but also enable oncology patients to maintain uninterrupted therapy.Expanding its pipeline to include non-oncology products, an opportunistic...
Sevaro Partners with Rosman Search to Elevate Neurology Services in Hospitals Nationwide
October 08, 2024 10:00 ET
|
Sevaro Health
Sevaro & Rosman Search partner to provide hospitals with advanced virtual neurology services & expert staffing, revolutionizing neurology care delivery.
Central Lab Market to hit USD 5.1 billion by 2032, says Global Market Insights Inc.
October 08, 2024 06:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Central Lab Market size was valued at approximately USD 3.1 billion in 2023. Projections indicate it will grow to around USD 5.1 billion by...
Adaptive Research Announces it has Begun Enrolling Patients in AriBio’s Phase 3 POLARIS-AD Clinical Trial
September 30, 2024 08:00 ET
|
Adaptive Research Inc
Adaptive Research announced it has begun enrolling patients in
AriBio’s Phase 3 POLARIS-AD Clinical Trial.